Concepedia

Publication | Open Access

Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200

DOIFull Paper Access

82

Citations

39

References

2019

Year

Daruka Mahadevan, Mark C. Lanasa, Charles M. Farber, Manjari Pandey, Maria Whelden, Susan J. Faas, Terrie L Ulery, Anjli Kukreja, Lan Li, Camille L. Bedrosian,
Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov, NCT00648739 registered April 1, 2008.

References

YearCitations

Page 1